These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28116487)

  • 1. Interleukin-1β is associated with coronary endothelial dysfunction in patients with mTOR-inhibitor-eluting stent implantation.
    Chibana H; Kajimoto H; Ueno T; Yokoyama S; Sasaki KI; Ohtsuka M; Koiwaya H; Nakayoshi T; Mitsutake Y; Itaya N; Sasaki M; Fukumoto Y
    Heart Vessels; 2017 Jul; 32(7):823-832. PubMed ID: 28116487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: the CREDENTIAL study.
    Mischie AN; Nazzaro MS; Fiorilli R; De Felice F; Musto C; Confessore P; Parma A; Boschetti C; Violini R
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E184-91. PubMed ID: 23359371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents.
    Mitsutake Y; Ueno T; Yokoyama S; Sasaki K; Sugi Y; Toyama Y; Koiwaya H; Ohtsuka M; Nakayoshi T; Itaya N; Chibana H; Kakuma T; Imaizumi T
    JACC Cardiovasc Interv; 2012 Sep; 5(9):966-73. PubMed ID: 22995884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
    Kim JW; Suh SY; Choi CU; Na JO; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ
    JACC Cardiovasc Interv; 2008 Feb; 1(1):65-71. PubMed ID: 19393147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study.
    Rusinaru D; Vrolix M; Verheye S; Chowdhary S; Schoors D; Di Mario C; Desmet W; Donohoe DJ; Ormiston JA; Knape C; Bezerra H; Lansky A; Wijns W;
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1141-50. PubMed ID: 25044635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
    Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction.
    Kim JW; Seo HS; Park JH; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    J Am Coll Cardiol; 2009 May; 53(18):1653-9. PubMed ID: 19406340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.
    Hamilos M; Sarma J; Ostojic M; Cuisset T; Sarno G; Melikian N; Ntalianis A; Muller O; Barbato E; Beleslin B; Sagic D; De Bruyne B; Bartunek J; Wijns W
    Circ Cardiovasc Interv; 2008 Dec; 1(3):193-200. PubMed ID: 20031678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Endothelial Dysfunction in Coronary Arteries with Bare Metal and 2
    Akiyama Y; Matoba T; Katsuki S; Takase S; Nakashiro S; Nakano Y; Noma K; Tsutsui H
    J Atheroscler Thromb; 2022 Mar; 29(3):379-392. PubMed ID: 33612554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of telmisartan against endothelial dysfunction after coronary drug-eluting stent implantation in hypertensive patients.
    Terashima M; Kaneda H; Nasu K; Matsuo H; Habara M; Ito T; Tanaka N; Rathore S; Kinoshita Y; Kimura M; Ehara M; Suzuki Y; Suzuki T
    JACC Cardiovasc Interv; 2012 Feb; 5(2):182-90. PubMed ID: 22361603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation.
    Liu X; Zhang R; Hou J; Wu J; Zhang M; Fang S; Wang X; Huang X; Tian J; Li H; Sun Y; Yu B
    Clin Sci (Lond); 2019 Apr; 133(7):869-884. PubMed ID: 30914441
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiographic and clinical characteristics of patients with acetylcholine-induced coronary vasospasm on follow-up coronary angiography following drug-eluting stent implantation.
    Ito S; Nakasuka K; Morimoto K; Inomata M; Yoshida T; Tamai N; Suzuki S; Murakami Y; Morino A; Shimizu Y; Sato K
    J Invasive Cardiol; 2011 Feb; 23(2):57-64. PubMed ID: 21297201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease.
    Niccoli G; Sgueglia GA; Cosentino N; Piro M; Toma A; Cataneo L; Fracassi F; Porto I; Leone AM; Burzotta F; Trani C; Crea F
    Eur J Prev Cardiol; 2012 Oct; 19(5):914-26. PubMed ID: 21840968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved endothelial vasomotor function after everolimus-eluting stent implantation.
    Roura G; Homs S; Ferreiro JL; Gomez-Lara J; Romaguera R; Teruel L; Sánchez-Elvira G; Ariza-Solé A; Gómez-Hospital JA; Cequier Á
    EuroIntervention; 2015 Oct; 11(6):643-9. PubMed ID: 25022229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial changes of coronary endothelial function and arterial healing after paclitaxel-eluting stent implantation.
    Mitsutake Y; Ueno T; Ikeno F; Yokoyama S; Sasaki K; Nakayoshi T; Itaya N; Chibana H; Sasaki M; Fukumoto Y
    Cardiovasc Interv Ther; 2016 Jan; 31(1):21-8. PubMed ID: 26113198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.
    Hamilos MI; Ostojic M; Beleslin B; Sagic D; Mangovski L; Stojkovic S; Nedeljkovic M; Orlic D; Milosavljevic B; Topic D; Karanovic N; Wijns W;
    J Am Coll Cardiol; 2008 Jun; 51(22):2123-9. PubMed ID: 18510958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs.
    van den Heuvel M; Sorop O; Batenburg WW; Bakker CL; de Vries R; Koopmans SJ; van Beusekom HM; Duncker DJ; Danser AH; van der Giessen WJ
    JACC Cardiovasc Interv; 2010 Jul; 3(7):723-30. PubMed ID: 20650434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation.
    Aoki Y; Ishikawa K; Miura K; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    J Cardiol; 2016 Mar; 67(3):236-40. PubMed ID: 26194867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent.
    Pendyala LK; Matsumoto D; Shinke T; Iwasaki T; Sugimoto R; Hou D; Chen JP; Singh J; King SB; Chronos N; Li J
    JACC Cardiovasc Interv; 2012 Apr; 5(4):436-44. PubMed ID: 22516402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.